The Fourth NCI Pancreatic Cancer Symposium, “Current Advances and Future Challenges in Research and Treatment,” will take place September 8-9, 2016, on the NIH campus. Laufey Amundadottir, Ph.D., an investigator in the Laboratory of Translational Genomics and a Steering Committee member of the NCI-Pancreatic Cancer Interest Group, has been involved in the planning as part of the organizing committee.
The symposium will present the latest research on the development, progression, early detection and treatment of pancreatic cancer. Topics covered range from tumor biology to genetics and epigenetics.
The symposium will include a presentation by Dr. Amundadottir on her research, in which she applies genetic and genomic strategies to identify germline variants associated with risk of pancreatic cancer and conducts functional analyses to reveal the biological mechanisms by which those variants influence risk.